Picture of Eli Lilly and Co logo

LLY Eli Lilly and Co Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Eli Lilly and Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
C2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line8,3186,1945,5826,2455,240
Depreciation
Deferred Taxes
Non-Cash Items-3,090-1361,9562,0042,868
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-1,687-747-1,023-0.8-3,055
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Cash from Operating Activities4,8376,5007,2617,5864,240
Capital Expenditures-1,354-2,029-1,873-2,985-7,392
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-6,729-230-889-778239
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-8,083-2,259-2,762-3,763-7,153
Financing Cash Flow Items-200-242-296-309-335
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,325-3,137-4,131-5,4073,496
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5,6611,320161-1,752752